SuperworthCamp4 Therapeutics shares outstanding CAMP
Diluted shares outstanding, averaged over each quarter, from 2023.
- Latest quarter, to Jun 30, 2026
- 57.9M
- On a year earlier
- +187.4%
- more shares
Camp4 Therapeutics had 57.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 187.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 53.6M | +12407% |
| FY2023 | 428.6K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 57.9M | +187% | |
| Q1 FY26 | 57.9M | +187% | |
| Q4 FY25 | 53.6M | n/a | |
| Q3 FY25 | 27.3M | +4793% | |
| Q2 FY25 | 20.2M | +4068% | |
| Q1 FY25 | 20.2M | +4200% | |
| Q3 FY24 | 557.4K | +39% | |
| Q2 FY24 | 483.6K | n/a | |
| Q1 FY24 | 468.7K | n/a | |
| Q4 FY23 | 428.6K | n/a | |
| Q3 FY23 | 400.4K | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Camp4 Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.